Related Experiment Videos
[Limulus amebocyte lysate assay for diagnosing intraamniotic infection]
M Mazor1, A Wiznitzer, W Chaim
1Division of Obstetrics and Gynecology, Soroka Medical Center of Kupat Holim.
Harefuah
|December 1, 1992
Summary
The Limulus amebocyte lysate (LAL) assay is a valuable tool for diagnosing intraamniotic infection in women experiencing preterm labor. This rapid test demonstrates high sensitivity and specificity, aiding in timely clinical decisions.
Area of Science:
- Obstetrics and Gynecology
- Infectious Diseases
- Diagnostic Microbiology
Context:
- Intraamniotic infection (IAI) is a significant complication in preterm labor.
- Accurate and timely diagnosis of IAI is crucial for maternal and fetal outcomes.
- Transabdominal amniocentesis is a method for obtaining amniotic fluid for diagnostic testing.
Purpose:
- To evaluate the diagnostic performance of the Limulus amebocyte lysate (LAL) assay for intraamniotic infection.
- To assess the LAL assay's ability to predict premature delivery in women with preterm labor.
Summary:
- The study assessed the Limulus amebocyte lysate (LAL) assay in 51 women with preterm labor and intact membranes.
- The LAL assay showed high sensitivity (81.8%) and specificity (97.5%) for detecting intraamniotic infection.
- The assay also demonstrated utility in predicting premature delivery, with a specificity of 90.9%.
Impact:
- The Limulus amebocyte lysate (LAL) assay offers a simple, rapid, and sensitive method for diagnosing intraamniotic infection.
- This diagnostic capability can potentially improve management strategies for preterm labor.
- Early detection of IAI using LAL may lead to better clinical outcomes for mothers and neonates.